Spermidine
Spermidine is a dietary polyamine that supports autophagy and mitophagy through EP300 inhibition and eIF5A hypusination. Its strongest human signal is the Kiechl 2018 Bruneck cohort, where higher dietary spermidine intake tracked with lower 20-year mortality. But the main cognition RCT, Schwarz 2022 SmartAge, missed its primary endpoint, and all published human efficacy trials used wheat germ extract rather than synthetic 3HCL.
Spermidine scored 6.0 / 10 (👍 Worth trying) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
What It Is
Spermidine is a dietary polyamine, a small molecule found across whole foods and made inside the body. It helps regulate autophagy, the cleanup process your cells use to break down worn-out proteins and organelles. It also supports mitophagy, the selective recycling of damaged mitochondria. Mechanistically, the two main levers are EP300 inhibition and eIF5A hypusination, which connect spermidine to autophagy, mitochondrial quality control, protein translation, and immune aging.
The strongest human signal is not a supplement trial. It is the Kiechl 2018 Bruneck cohort, which followed 829 adults for 20 years and found that higher dietary spermidine intake tracked with lower all-cause mortality. That matters, but it is still observational. The cleanest mechanistic paper is Eisenberg 2016, where spermidine extended lifespan and improved cardiac aging markers in animals, with autophagy required for key cardiac benefit.
Human trial evidence is narrower. Schwarz 2022 SmartAge tested 0.9 mg/day wheat germ extract for 12 months in 100 older adults with subjective cognitive decline and missed the primary memory endpoint. Rinaldi 2017 found a spermidine-based supplement improved hair follicle cycling markers over 90 days. The 2024-2026 update did not find a new completed n>=100 spermidine-only efficacy RCT, though Thorup 2025 POLYCAD is an important coronary artery disease protocol with results expected after this cutoff.
In practice, spermidine is a slow compounding intervention. You do not take it for an acute energy shift. You take it because polyamine intake declines with age, dietary exposure varies wildly, and the autophagy mechanism is one of the better-supported longevity pathways. The key distinction is form: the 7.0 score applies mostly to wheat germ extract and food-first spermidine. Synthetic 3HCL is cheaper and common, but its human outcome evidence is still incomplete.
Terminology
For regulatory context, see the EU Novel Food regulation and the FDA GRN 889 record.
- Spermidine: A natural polyamine found in foods and human cells.
- Polyamines: Small positively charged molecules involved in cell growth, stress response, autophagy, and protein translation.
- WGE: Wheat germ extract, the natural food-derived form used in the main published human trials.
- 3HCL: Spermidine trihydrochloride, the synthetic salt form common in US supplements.
- Autophagy: Cellular recycling. Cells break down and reuse damaged parts.
- Mitophagy: Autophagy targeted specifically at damaged mitochondria.
- EP300: An acetyltransferase enzyme. Spermidine inhibits EP300, which helps trigger autophagy signaling.
- eIF5A: Eukaryotic translation initiation factor 5A, a protein that requires hypusination for proper function.
- Hypusination: A rare post-translational modification unique to eIF5A.
- PINK1: A mitochondrial quality-control kinase involved in tagging damaged mitochondria for cleanup.
- ATG3: An autophagy protein needed for autophagosome formation.
- DFMO: Difluoromethylornithine, a drug that inhibits polyamine synthesis and conflicts with spermidine supplementation logic.
- Bruneck cohort: Prospective Italian population study used in the key dietary spermidine mortality analysis.
- SmartAge: The 12-month Schwarz 2022 cognition RCT testing low-dose wheat germ extract.
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
View 3 routes and 6 protocols
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral (WGE) | Wheat germ extract capsule or tablet | 1-3 mg/day wheat germ extract | 1-6 mg/day |
| Oral (Synthetic 3HCL) | Spermidine trihydrochloride capsule or powder | No completed human outcome RCT dose established | 5-15 mg/day synthetic 3HCL |
| Food / Whole Foods | Wheat germ, natto, aged cheese, mushrooms, soybeans, edamame, fermented vegetables | Dietary intake, not a standardized trial dose | 5-10 mg/day from food pattern |
Protocols
WGE low-dose maintenance Clinical
- Dose
- 1-3 mg/day oral WGE
- Frequency
- Daily
- Duration
- Indefinite
Single capsule with breakfast. Best fit for users who want to stay close to the published human WGE evidence base.
WGE EU-capped dose Clinical
- Dose
- 3-6 mg/day oral WGE
- Frequency
- Daily
- Duration
- Indefinite
Upper adult range under EU Novel Food authorization for specific wheat germ extract preparations. Pregnancy and lactation excluded.
Synthetic 3HCL aggressive Anecdotal
- Dose
- 10 mg/day oral synthetic 3HCL
- Frequency
- Daily
- Duration
- Indefinite
Common enthusiast protocol. Accepts form-extrapolation risk because no completed human outcome RCT confirms synthetic 3HCL parity with WGE.
Food-first approach Anecdotal
- Dose
- Roughly 5-10 mg/day from whole foods
- Frequency
- Daily
- Duration
- Lifestyle
Cheapest and closest to the dietary cohort evidence. Harder to sustain than capsules, but brings fiber, micronutrients, and fermented-food benefits.
Spermidine + resveratrol stack Mixed
- Dose
- 2-3 mg spermidine + 250-500 mg resveratrol
- Frequency
- Daily
- Duration
- Indefinite
Targets complementary longevity pathways. Evidence for the exact stack is not outcome-proven in humans.
Spermidine + rapamycin stack Mixed
- Dose
- 2-3 mg spermidine daily + rapamycin per clinician-supervised protocol
- Frequency
- Daily spermidine, rapamycin per protocol
- Duration
- Indefinite
Use only when rapamycin is already medically supervised. This is a mechanistic stack, not a proven clinical endpoint protocol.
Use-Case Specific Dosing
| Use Case | Dose | Notes |
|---|---|---|
How this score is calculated →
Upside contribution: 2.88
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 2.8 | 0.700 | |
| Breadth of Benefits | 15% | 4.0 | 0.600 | |
| Evidence Quality | 25% | 2.8 | 0.700 | |
| Speed of Onset | 10% | 1.5 | 0.150 | |
| Durability | 10% | 2.0 | 0.200 | |
| Bioindividuality Upside | 15% | 3.5 | 0.525 | |
| Total | 2.875 |
Upside Rationale
Spermidine's upside is a plausible autophagy and cardiometabolic aging signal with familiar food exposure, but the useful read is narrower than the marketing version. Kiechl 2018 supports the main direction of benefit, and Eisenberg 2016 helps explain where that signal may matter in real use. Mechanistically, spermidine supports autophagy and polyamine biology involved in cell cleanup, which makes the intervention plausible across several BioHarmony use cases. The strength is strongest when the goal matches dietary intake, inflammatory markers, cardiovascular markers, hair metrics, cognition, or tolerance. Spermidine is weaker when the goal is vague optimization, because dietary intake, wheat-germ extracts, and purified capsules are not interchangeable evidence streams. That makes Spermidine a reasonable tool when the experiment is specific, measured, and time-bounded.
Efficacy (2.8/5.0). Spermidine has meaningful but not decisive efficacy. The best human signal is Kiechl 2018: a 20-year cohort linking higher dietary spermidine intake with lower all-cause mortality. The best mechanistic support is Eisenberg 2016, where aged animals showed cardiac and lifespan benefits and autophagy was required for core cardioprotection. The human trial picture is mixed. Rinaldi 2017 supports hair follicle cycling, while Schwarz 2022 missed the primary cognition endpoint. That combination earns a positive score, but not a top-tier one.
Breadth of benefits (4.0/5.0). Polyamines sit upstream of autophagy, mitophagy, protein translation, immune-cell function, and mitochondrial quality control. That gives spermidine a wider theoretical surface area than targeted supplements like urolithin A or creatine. Verified evidence touches cardiovascular aging, longevity, cognition, hair biology, liver autophagy, immune aging, and gut-microbiome aging reviews. Yue 2017 extends the liver and cancer-prevention mechanism in animals. Yu 2024 updates the gut microbiota and aging lens. The breadth is real, but many endpoints remain preclinical or secondary.
Evidence quality (2.8/5.0). This is moderate evidence with integrity caveats. On the plus side, the Bruneck cohort is long, the animal mechanism is unusually coherent, and the Rinaldi hair RCT is positive. On the minus side, the flagship cognition RCT was null on its primary endpoint, no Cochrane review exists, and no cardiovascular society, USPSTF, or NICE guidance endorses spermidine supplementation. The 2024-2026 audit found Gai 2025, Keohane 2024, Bruno 2025, and the POLYCAD protocol, but no new completed n>=100 spermidine-only efficacy RCT.
Speed of onset (1.5/5.0). Spermidine is slow. Hair follicle cycling was measured over 90 days in Rinaldi 2017. Cognition was tested over 12 months in Schwarz 2022 without a significant primary memory win. The Bruneck mortality signal reflects decades of dietary exposure. Users should not expect a first-week subjective shift, a same-day energy effect, or a fast biomarker change. If you need something you can feel quickly, this is the wrong tool.
Durability (2.0/5.0). Benefits likely depend on ongoing intake. Spermidine is a dietary polyamine, not a one-time adaptation. The Bruneck signal reflects sustained food patterns, not a short course. If intake stops, cellular autophagy tone should return toward whatever your baseline diet and metabolism support. There is no evidence that a short spermidine cycle creates durable benefits after discontinuation. Treat it like protein, fiber, or creatine-adjacent maintenance, not like a procedure.
Bioindividuality (3.5/5.0). The best responders are probably older adults, people with low polyamine intake, people who rarely eat wheat germ or fermented foods, and those with lab evidence of low polyamine status. People already eating natto, mushrooms, aged cheese, legumes, and wheat germ daily may see smaller marginal benefit. Cancer history, DFMO use, pregnancy, lactation, and celiac disease all change the risk-benefit calculation. This is not a universal green light.
Downside contribution: 1.87 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety Risk | 30% | 1.8 | 0.540 | |
| Side Effect Profile | 15% | 1.3 | 0.195 | |
| Financial Cost | 5% | 2.5 | 0.125 | |
| Time/Effort Burden | 5% | 1.2 | 0.060 | |
| Opportunity Cost | 5% | 1.3 | 0.065 | |
| Dependency / Withdrawal | 15% | 1.0 | 0.150 | |
| Reversibility | 25% | 1.1 | 0.275 | |
| Total | 1.410 | |||
| Harm subtotal × 1.4 | 1.624 | |||
| Opportunity subtotal × 1.0 | 0.250 | |||
| Combined downside | 1.874 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 0.534 |
Downside Rationale
Spermidine's downside starts with translation from diet and animals to capsule outcomes, not with a simple claim that Spermidine is dangerous for everyone. Schwarz 2022 is the most useful caution anchor in the verified pool, and the broader tradeoff is that dietary intake, wheat-germ extracts, and purified capsules are not interchangeable evidence streams. The risk also depends on context: allergies, GI tolerance, unclear high-dose use, product form, and weak human endpoint data can change the equation fast. That matters because a modest or uncertain upside has to clear a higher bar when the user has contraindications, poor tracking, or unrealistic expectations. In practice, Spermidine deserves a narrow trial, conservative dosing or exposure, and a stop rule tied to dietary intake, inflammatory markers, cardiovascular markers, hair metrics, cognition, or tolerance.
Safety risk (1.8/5.0). Normal WGE dosing looks low-risk for healthy adults, but the authority audit required claim tempering. FDA has not approved spermidine as a drug. FDA GRN 889 did not end in a no-questions letter; evaluation stopped at the notifier's request. EU Novel Food status supports specific authorized food uses, not therapeutic endorsement. The biggest safety issue is context: active cancer, DFMO protocols, pregnancy, lactation, and wheat/gluten exposure. The FDA recall category also supports real allergen vigilance for products sold as spermidine supplements.
Side effect profile (1.3/5.0). Side effects are usually mild. Schwarz 2022 did not show a concerning safety pattern over 12 months, and Keohane 2024 found short-term high-dose 3HCL was tolerated in a small older-male sample. In practice, the common complaints are bloating, nausea, or GI discomfort, especially at higher doses or on an empty stomach. No consistent sleep, mood, hormone, liver, or kidney signal is established in verified human trials.
Financial cost (2.5/5.0). The cost depends entirely on form. Branded wheat germ extract usually lands around $40-90/month. Synthetic 3HCL can run $15-30/month. Food-first wheat germ can be cheaper, often close to $10/month, but only if you actually eat it daily. The score reflects a motivated user choosing a legitimate channel rather than a luxury concierge brand. WGE costs more, but it is also the better-studied form.
Time / effort burden (1.2/5.0). Capsules are easy: one dose per day, with or without food. There is no loading phase, cold chain, special timing window, or required lab monitoring for healthy adults. Food-first dosing adds a little prep: wheat germ over yogurt, natto with meals, mushrooms, legumes, or aged cheese. Compared with rapamycin, sauna, NAD+ IVs, or strict fasting, the operational burden is low.
Opportunity cost (1.3/5.0). Spermidine stacks cleanly with the basics: resistance training, zone 2 cardio, protein, fiber, sleep, urolithin A, NMN, NR, and rapamycin when medically supervised. The one hard conflict is DFMO. The main opportunity cost is psychological: people may overrate a capsule while ignoring the food pattern that generated the best human signal.
Dependency / withdrawal (1.0/5.0). No dependency signal exists. Spermidine is a dietary molecule found in normal foods, not a stimulant, sedative, hormone, or reward-circuit drug. Stopping it should return you to baseline intake rather than cause withdrawal. No tolerance escalation or rebound syndrome is documented in verified human trials.
Reversibility (1.1/5.0). Reversibility is excellent. Stop the capsule or food emphasis and exposure falls back toward baseline. There is no surgery, device implantation, permanent receptor change, or durable structural commitment. The downside is that benefits probably fade too. For a longevity supplement, that is a reasonable tradeoff.
Verdict
Spermidine is a 6/10 fit for people interested in food-based autophagy and healthy-aging signals, especially when they can track diet and biomarkers, because spermidine has solid mechanistic and cohort support, but supplement trials are still early. Kiechl 2018 gives the strongest anchor, while Eisenberg 2016 adds useful context without closing the case. The honest gap is simple: dietary intake, wheat-germ extracts, and purified capsules are not interchangeable evidence streams. That puts Spermidine in the tracked-experiment category, not the automatic-staple category. In practice, Spermidine makes the most sense when you monitor dietary intake, inflammatory markers, cardiovascular markers, hair metrics, cognition, or tolerance and avoid treating Spermidine like a proven autophagy longevity pill.
✅ Best for: Healthy adults over 40 who want a low-effort, food-derived autophagy lever with a strong dietary signal and a clean day-to-day safety profile. People whose TruDiagnostic, Function Health, or similar panels suggest low polyamine status. Cardiovascular-risk populations using spermidine only as an adjunct to standard care, not a replacement. Post-menopausal women concerned about hair density, where Rinaldi 2017 gives the most practical human RCT signal. Users who already have sleep, exercise, protein, and cardiometabolic basics handled and want a slow, low-friction longevity add-on. Food-first users willing to eat wheat germ, natto, mushrooms, legumes, and fermented foods consistently.
❌ Avoid if: You have active cancer unless your oncology team explicitly clears it. You are using DFMO or any protocol designed to restrict polyamine metabolism. You are pregnant or lactating. You have celiac disease and cannot verify a gluten-tested WGE product. You expect noticeable effects in days or weeks. You want Phase 3 RCT proof before supplementing. You are buying synthetic 3HCL while assuming it has the same evidence base as WGE. Athletes should also verify product quality carefully because WADA 2026 does not name spermidine as prohibited, but contamination risk still exists.
Use Case Breakdown
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Longevity / Lifespan: 7.5/10
Score: 7.5/10The practical longevity read on Spermidine is 7.5/10 because Kiechl 2018 anchors the strongest signal. The existing rationale points to this narrower claim: this verified source is the strongest human signal, with 20-year dietary follow-up linking higher spermidine intake to lower all-cause mortality; this verified. That does not make Spermidine a targeted longevity treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track harder biomarkers, frailty markers, and function, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Autophagy: 8.0/10
Score: 8.0/10Spermidine's 8.0/10 autophagy score starts with Eisenberg 2016, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: this verified source shows autophagy dependence in animal cardioprotection; this verified source reviews spermidine's autophagy-centered anti-aging case. That does not make Spermidine a targeted autophagy treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track symptoms, labs, performance, recovery, and a clear before-after marker, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Cardiovascular: 7.8/10
Score: 7.8/10Spermidine earns 7.8/10 for cardiovascular because Kiechl 2018 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: this verified source supports cardiac autophagy and diastolic-function mechanisms in animals; this verified source provides the strongest human dietary mortality and cardiovascular-risk. That does not make Spermidine a targeted cardiovascular treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track heart rate, pace, blood pressure, and recovery, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Hair / Nail Health: 6.8/10
Score: 6.8/10A 6.8/10 for hair-nail fits Spermidine because Schwarz 2022 supports direction more than certainty. The existing rationale points to this narrower claim: this verified source randomized 100 participants and found a spermidine-based supplement improved hair follicle cycling markers over 90 days. That does not make Spermidine a targeted hair-nail treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track photos, shedding, skin quality, and time to visible change, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Mitochondrial: 6.5/10
Score: 6.5/10The mitochondrial case for Spermidine is 6.5/10 because Schwarz 2022 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: this verified source supports autophagy-dependent cardiac benefits; spermidine's eIF5A and mitophagy biology make mitochondrial quality control a core rationale. That does not make Spermidine a targeted mitochondrial treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track training capacity, fatigue, and repeatable output, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Immune Function: 6.2/10
Score: 6.2/10For immune-function, Spermidine lands at 6.2/10 because Eisenberg 2016 supports the strongest part of the claim. The existing rationale points to this narrower claim: T-cell autophagy and immune-aging signals are part of the mechanistic case, but the audit could not verify the prior Alsaleh PMID, so. That does not make Spermidine a targeted immune-function treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track infection frequency, recovery time, and inflammatory markers, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Geriatric / Aging Population: 7.2/10
Score: 7.2/10On geriatric, Spermidine deserves 7.2/10 because Schwarz 2022 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Older adults are the clearest target population across this verified source and this verified source. That does not make Spermidine a targeted geriatric treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track symptoms, labs, performance, recovery, and a clear before-after marker, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Healthspan: 7.0/10
Score: 7.0/10Spermidine earns 7.0/10 for healthspan because Eisenberg 2016 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: Broad autophagy effects support healthspan, but the human outcomes remain mostly dietary observational plus small RCTs. That does not make Spermidine a targeted healthspan treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track daily function, recovery, labs, and resilience, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Cellular Senescence: 6.5/10
Score: 6.5/10The cellular-senescence case for Spermidine is 6.5/10 because Kiechl 2018 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Autophagy clears senescence-associated cellular damage in mechanistic and animal models, but no human senescence endpoint is established. That does not make Spermidine a targeted cellular-senescence treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track symptoms, labs, performance, recovery, and a clear before-after marker, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Skin / Beauty: 5.5/10
Score: 5.5/10On skin-beauty, Spermidine deserves 5.5/10 because Eisenberg 2016 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Autophagy gives a coherent skin-aging rationale, but verified human dermatology evidence is much narrower than the mechanism suggests. That does not make Spermidine a targeted skin-beauty treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track photos, shedding, skin quality, and time to visible change, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Liver / Detoxification: 5.2/10
Score: 5.2/10Spermidine's 5.2/10 liver-detox score starts with Kiechl 2018, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: this verified source supports liver fibrosis and hepatocellular-carcinoma prevention mechanisms in animals through autophagy, but there are no human liver-outcome RCTs. That does not make Spermidine a targeted liver-detox treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track symptoms, labs, performance, recovery, and a clear before-after marker, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
Anti-Inflammatory: 5.0/10
Score: 5.0/10For anti-inflammatory, Spermidine lands at 5.0/10 because Schwarz 2022 supports the strongest part of the claim. The existing rationale points to this narrower claim: this verified source measured biomarkers in older adults, but anti-inflammatory benefit remains secondary rather than proven as a primary endpoint. That does not make Spermidine a targeted anti-inflammatory treatment. The report's best evidence is mostly autophagy mechanisms, dietary cohort data, and small extract trials rather than proven capsule outcomes, so the score is directional rather than settled. Track symptoms, labs, performance, recovery, and a clear before-after marker, then stop if the signal is absent or the tradeoff becomes larger than the benefit.
| Use Case | Score | Summary |
|---|---|---|
| ⚖️ Stem Cell Support | 4.8 | Autophagy supports stem-cell maintenance in preclinical biology, but human outcome evidence is limited. |
| ○ Cognition / Focus | 4.5 | Schwarz 2022 SmartAge found no significant primary memory benefit after 12 months, though exploratory signals kept cognition from scoring lower. |
| ○ Neuroprotection | 4.5 | Autophagy and mitophagy support the neuroprotection thesis, but verified human neurodegeneration outcomes are not available. |
| ○ Telomere / DNA Repair | 4.5 | Weak telomere and genomic-maintenance signal; not a primary mechanism in verified human evidence. |
| ○ Metabolic Health | 4.2 | Gai 2025 reviews anti-aging and metabolic endpoints, but the human metabolic evidence is not strong enough to make this a primary use case. |
| ○ Memory | 4.2 | Schwarz 2022 did not hit the primary memory endpoint, so the memory score stays modest despite mechanistic interest. |
| ○ Recovery / Repair | 4.0 | Autophagy supports cellular recovery, but verified human recovery trials are indirect or absent. |
| ○ Antioxidant / Oxidative Stress | 4.0 | Indirect antioxidant role via mitophagy and cleanup of damaged cellular components. |
| ○ Neuroplasticity | 3.8 | Autophagy supports neural maintenance, but verified human neuroplasticity evidence is not clean. |
| ○ Fertility (Male) | 3.8 | Animal sperm-quality signal only; no verified human RCT. |
| ○ Gut Health / Microbiome | 3.5 | Yu 2024 reviews gut microbiota, aging, and spermidine, but human gut-outcome RCT evidence remains limited. |
| ○ Kidney Function | 3.5 | No clear positive or negative kidney-function signal in verified human outcome data. |
| ○ Eye / Vision Health | 3.5 | Autophagy is relevant to retinal aging, but no verified human spermidine outcome trial supports an eye-specific claim. |
| ○ Endurance / Cardio | 3.5 | Cardiovascular aging rationale exists via Kiechl 2018, but there are no exercise-performance RCTs. |
| ○ Methylation Support | 3.5 | Polyamine and methionine-cycle crosstalk exists, but no human outcome data make methylation a primary use case. |
| ○ Wound Healing | 3.5 | Animal wound-healing rationale exists, but no human wound-healing RCT support was verified. |
| ○ Energy / Fatigue | 3.5 | Indirect via mitochondrial quality control; no subjective-energy RCT. |
| ○ Nerve Regeneration | 3.0 | Animal nerve-injury models only. |
| ○ Injury Recovery | 3.0 | Autophagy supports recovery biology, but no verified RCTs test spermidine in injury recovery. |
| ○ Traumatic Brain Injury | 3.0 | Autophagy rationale only; no TBI RCTs. |
Frequently Asked Questions
What does spermidine actually do in the body?
Spermidine supports autophagy, the cleanup process cells use to recycle damaged parts, and mitophagy, the selective cleanup of worn-out mitochondria. The main mechanisms are EP300 acetyltransferase inhibition and eIF5A hypusination, which helps translate proteins involved in mitochondrial quality control. Eisenberg 2016 strengthened the on-target case by showing cardiac benefits in aged animals and loss of key benefit when autophagy was disrupted.
How much spermidine should I take and in what form?
The cleanest evidence-based range is 1-3 mg/day of wheat germ extract, because the main human trials used WGE-style preparations. Schwarz 2022 used 0.9 mg/day for 12 months, while Rinaldi 2017 used a spermidine-based supplement for hair-cycle endpoints. EU Novel Food authorization caps adult use of specific WGE preparations at 6 mg/day. Synthetic 3HCL is commonly used at higher enthusiast doses, but outcome data are not yet there.
Is the evidence for spermidine actually strong?
Moderate, not definitive. Kiechl 2018 is a strong 20-year dietary cohort signal, and Eisenberg 2016 provides unusually clean mechanism support. But the best-known cognition RCT, Schwarz 2022 SmartAge, missed its primary endpoint. Rinaldi 2017 supports hair follicle cycling, but that does not prove broad longevity outcomes. No Cochrane review or major medical-society endorsement exists yet.
Natural wheat germ extract vs synthetic spermidine 3HCL: does the form matter?
Yes, for evidence quality. Every published human efficacy trial in the v0.x evidence base used wheat germ extract or a spermidine-based natural product, not isolated synthetic 3HCL. Synthetic 3HCL may still work, but that is extrapolation. Keohane 2024 found 40 mg/day high-purity spermidine trihydrochloride was tolerated over 28 days in older men, but it minimally changed circulating polyamines and did not test clinical outcomes. If you want the studied form, choose WGE.
Is spermidine safe long-term?
For healthy adults using normal WGE doses, the safety profile looks clean. Schwarz 2022 found balanced safety findings over 12 months, and Keohane 2024 found short-term high-dose 3HCL tolerability in a small older-male trial. The practical issues are mild GI upset, wheat or gluten exposure from WGE, and the active-cancer problem. FDA has not approved spermidine as a drug, and GRN 889 did not end in a no-questions letter.
Who should NOT take spermidine?
Avoid spermidine if you have active cancer unless your oncology team specifically approves it, because polyamine metabolism can matter in tumor biology. Avoid it if you are on DFMO, because DFMO intentionally restricts polyamine synthesis. Pregnant and lactating women should skip it because EU Novel Food authorization excludes those groups. People with celiac disease should avoid wheat germ extract unless the product is explicitly gluten-tested. Athletes should treat supplement quality seriously because WADA does not name spermidine as prohibited, but contamination still matters.
How fast does spermidine work?
Slowly. Spermidine is not a same-day energy supplement. Rinaldi 2017 measured hair follicle cycling over 90 days. Schwarz 2022 tested cognition over 12 months and still did not hit the primary endpoint. Kiechl 2018 reflects decades of diet exposure. In practice, take it only if you are comfortable with a long-horizon intervention that may never produce a distinct felt effect.
Can I just eat foods rich in spermidine instead?
Yes. The Kiechl 2018 longevity signal is dietary, not capsule-based. The easiest food sources are fresh wheat germ, natto, aged cheeses, mushrooms, soybeans, edamame, and fermented vegetables. A food-first strategy is cheaper and brings other nutrients with it. The downside is consistency: most people will not eat wheat germ or natto every day for years. My practical approach is capsule for insurance, food for substrate.
How This Score Could Change
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
| Scenario | Dimensions changed | New score |
|---|---|---|
| Large cardiovascular outcomes RCT with 2,000+ participants and 3+ years replicates the Bruneck direction | Evidence 2.8 to 4.0; Efficacy 2.8 to 3.5; Durability 2.0 to 3.0 | 7.6 / 10 ✅ Top-tier |
| POLYCAD reports positive coronary artery disease outcomes after completion | Evidence 2.8 to 3.5; Cardiovascular subrating 7.8 to 8.5 | 7.1 / 10 💪 Strong recommend |
| SmartAge follow-up or a higher-dose cognition RCT shows significant memory benefit | Evidence 2.8 to 3.3; Efficacy 2.8 to 3.2 | 6.9 / 10 💪 Strong recommend |
| First synthetic 3HCL head-to-head RCT shows parity with WGE | Evidence 2.8 to 3.2; Efficacy 2.8 to 3.0; synthetic-form confidence improves | Synthetic form: 6.6 / 10 👍 Worth trying |
| New T-cell suppression signal appears in healthy adults, not only tumor contexts | Safety 1.8 to 2.8; Evidence 2.8 to 2.5 | 5.4 / 10 👍 Worth trying |
| WGE gets reclassified with stronger celiac or allergen warnings | Safety 1.8 to 2.2; Bioindividuality 3.5 to 3.0 | 6.0 / 10 👍 Worth trying |
Key Evidence Sources
- Kiechl S et al. 2018 - Higher spermidine intake is linked to lower mortality: a prospective population-based study, American Journal of Clinical Nutrition. Confirmed PMID 29955838; Bruneck cohort, n=829, 20-year follow-up; higher dietary spermidine intake associated with lower all-cause mortality
- Eisenberg T et al. 2016 - Cardioprotection and lifespan extension by the natural polyamine spermidine, Nature Medicine. Confirmed PMID 27841876 and PMCID PMC5806691; animal lifespan and cardiac data, with autophagy dependence in cardiomyocyte Atg5-deficient mice
- Schwarz C et al. 2022 - Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial, JAMA Network Open. Corrected v0.x PMID mismatch; confirmed PMCID PMC9136623; n=100, 0.9 mg/day wheat germ extract for 12 months; no significant primary memory benefit
- Rinaldi F et al. 2017 - The effect of a spermidine-based nutritional supplement on hair follicle physiology: a randomized, double-blind, placebo-controlled study, Dermatology Practical & Conceptual. Corrected v0.x PMID mismatch; confirmed PMID 29214104 and PMCID PMC5718121; n=100; improved hair follicle cycling markers
- Yue F et al. 2017 - Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy, Cancer Research. Confirmed PMID 28386016 and PMCID PMC5489339; mouse and cell data support liver autophagy and HCC-prevention mechanism
- Yu L et al. 2024 - Gut microbiota and anti-aging: Focusing on spermidine, Critical Reviews in Food Science and Nutrition. Verified review focused on gut microbiota, aging, and spermidine; mechanistic and preclinical emphasis
- Gai X 2025 - The beneficial effects of spermidine via autophagy: a systematic review, Theoretical and Natural Science. Verified systematic review; narrative synthesis across anti-aging, cardiovascular, neurologic, and metabolic endpoints; highlights research gaps
- Thorup C et al. 2025 - POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial, Trials. Verified protocol; n=187 elderly CAD patients; 24 mg/day spermidine or placebo for 48 weeks; results anticipated after current cutoff
- Keohane KM et al. 2024 - Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men, Nutrition Research. Verified small RCT; n=37 older men; 40 mg/day high-purity spermidine trihydrochloride for 28 days was well tolerated but minimally changed circulating polyamines
- Bruno EJ et al. 2025 - Effects of Spermidine-Rich Rice Germ Extract Supplement on Biomarkers of Healthy Aging and Autophagy, Alternative Therapies in Health and Medicine. Verified pilot; n=12; rice-germ spermidine improved selected biomarkers versus baseline; small proof-of-concept only
- Felix J et al. 2024 - Human Supplementation with AM3, Spermidine, and Hesperidin Enhances Immune Function, Decreases Biological Age, and Improves Oxidative-Inflammatory State: A Randomized Controlled Trial, Antioxidants. Verified RCT of a combination product; useful for safety and immune-marker context but not spermidine-isolated efficacy
- European Commission 2017 - Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods. Authority source for EU Novel Food status and use constraints for authorized novel foods
- FDA GRN 889 - Spermidine-rich wheat germ extract notice inventory. Authority source; audit found FDA ceased evaluation at notifier request, so this is not a no-questions letter or drug endorsement
- FDA 2025 - Spermidine supplement recall for undeclared wheat allergen. Authority source category supporting wheat-allergen vigilance for spermidine supplements
- WADA 2026 - World Anti-Doping Code International Standard Prohibited List. Authority source; spermidine was not found as a named prohibited substance in fetched WADA material, but supplement contamination risk remains
- Cochrane Library 2026 - targeted search for spermidine supplementation reviews. Authority gap; audit found no Cochrane review specific to spermidine supplementation for longevity, cognition, cardiovascular prevention, autophagy, or hair outcomes
- USPSTF 2026 - preventive recommendation search for spermidine. Authority gap; no USPSTF recommendation found for spermidine supplementation
- NICE 2026 - guidance search for spermidine. Authority gap; no NICE guidance found recommending spermidine for cognition, cardiovascular disease, hair loss, longevity, or healthy aging
Holistic Evidence Profile
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Medium
Citations: Kiechl 2018, Eisenberg 2016, Schwarz 2022, Rinaldi 2017, Yue 2017, Yu 2024, Gai 2025, Thorup 2025, Keohane 2024, Bruno 2025
Pre-RCT-Era Pharmacology and Use
Confidence: Medium
Traditional Medicine Systems
Confidence: Low
Holistic Evidence for Spermidine
All three lenses point to the same honest read: spermidine is more convincing as a slow food-derived autophagy and healthy-aging lever than as a fast therapeutic. Modern science gives the mechanism and the best human signal, but it also exposes the limitation: the main cognition RCT was null, and supplement-specific outcome data are thin. Historical and traditional food patterns make daily polyamine exposure normal, especially through fermented foods. The v1.0 score stays strong, but the claim should remain tempered until POLYCAD or another large human endpoint trial reports.
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Bloodwork to Order
Open These Markers In Your Dashboard
- hs-CRP Baseline (pre-protocol) During | Expected Down
- ALT During | Expected Stable
Pulse Dimensions to Watch
- Body During | Expected Watch | Primary
- Energy During | Expected Watch | Secondary
- Sleep During | Expected Stable | Tertiary
Subjective Signals (Daily Voice Card)
- GI Comfort Scale 1-5 | During | Expected Watch
- Hair Or Nail Changes Scale 1-5 | During | Expected Watch
- Energy Stability Scale 1-5 | During | Expected Watch
Red Flags: Stop and Consult
- Persistent GI distress
- New rash or allergic reaction
Other interventions for Longevity
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–3.6, Caution 3.7–4.7, Neutral 4.8–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–7.9, Top-tier 8.0+.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.875 − 0.534 = 1.341
Formula v0.5 maps EV = 0 to score 5.0. Above neutral, 1 EV point equals 1 score point. Below neutral, 1 EV point equals about 0.71 score points, so EV = −7 reaches 0.0 while EV = +5 reaches 10.0. Both sides use the full 5-point half-scale.
Score = 5 + (1.341 / 5) × 5 = 6.3 / 10
Further learning
Only 7+ Best Spermidine Supplements Review 2026: Read BEFORE Buying
Anti-aging researchers have their eyes on spermidine. But good products are hard to find.
The Ancient Japanese Longevity Scrolls & Spermidine
Leslie Kenny, founder of Oxford Healthspan, delves into the science of spermidine—a naturally occurring compound that activates autophagy, the body's cellular clean-up process. She…
